I’ve said this before and I can’t stress it enough.ASX companies...

I’ve said this before and I can’t stress it enough.ASX companies like Imugene don’t come around too often ( if ever at all )
The main reason being is that it’s very rare for a company to disrupt such a massive global market, a market that transcends age/sex/status/wealth/location etc.

combine that with the multiple game changing treatments in the pipeline, An experienced Exec Chair who has overseen big pharma deals before, An Outstanding CEO who’s held senior positions for the like of Roche & Genentech, clinical trials at some of the worlds most prestigious hospitals & a long standing patent fortress surrounding the IP of its products. It’s at this point you can start to understand why it’s seen such an incremental rise.

but......I’m here to tell you, that if you think the run up to 49 cents is all that Imugene has left in the tank, then you are seriously underestimating it’s potential & will be in for a rude awakening in 6 months to a year from now.

know the value of your shares....don’t give them away to the big guys trying to shake you down